October 28th 2024
Before marketing your pharmacy’s immunizations services, check out these takeaways from NCPA.
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
View More
Psychotropic Drugs in Pediatrics: Looking at the Whole Child
December 21st 2018Each year, approximately 200,000 children ages 17 years and younger land in emergency departments (EDs) from adverse drug events (ADEs). Children younger than 5 years of age are most likely to visit the ED for ADEs, according to the CDC.
APP Pharmaceuticals releasing more preservative-free methotrexate
March 15th 2012Continuing to work with FDA to ease the ongoing shortage of injectable methotrexate, APP Pharmaceuticals this week released another 10,000 vials of preservative-free methotrexate (Methotrexate Injection), a drug used in the treatment of pediatric oncology and hematology
First synthetic, peptide-containing surfactant for prevention of RDS approved
March 8th 2012FDA has approved lucinactant (Surfaxin, Discovery Labs) for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS. Surfaxin is the first synthetic, peptide-containing surfactant approved for use in neonatal medicine.
Zinc plus antibiotics saves lives of children with pneumonia, study finds
February 23rd 2012Zinc used in addition to antibiotics significantly reduced mortality in children ages 6 months to 59 months with severe pneumonia when compared with antibiotics alone, according to the findings of a recent study done in Uganda.
Infants' Tylenol medication recalled by McNeil after dosing-system complaints
February 21st 2012More than a half million bottles of Infants' Tylenol Oral Suspension, 1 oz. grape, have been recalled voluntarily by McNeil Consumer Healthcare because of complaints about using the dosing system, the company announced.
Actavis launches generic equivalent of long-acting ADHD drug, with 180-day exclusivity
January 24th 2012FDA recently approved methylphenidate hydrochloride extended-release capsules (LA) CII, USP, the generic equivalent of Ritalin LA. Actavis Group, an international generic pharmaceuticals company, received first-to-file exclusivity on the 20-mg, 30-mg, and 40-mg strengths.
Overweight children have increased blood pressure risk, study finds
October 18th 2011Children who are overweight or obese have 3 times as much risk of high blood pressure as children of normal weight have, reported a study published recently in Hypertension: Journal of the American Heart Association.
FDA approves 2 new strengths of leuprolide acetate to treat children with CPP
August 17th 2011FDA has approved 2 new strengths (11.25 mg and 30 mg) for 3-month administration of leuprolide acetate for depot suspension (Lupron Depot-PED, Abbott) for the treatment of children with central precocious puberty.
FDA approves first meningococcal vaccine for infants and toddlers
May 10th 2011FDA approved the use of meningococcal (A, C, Y, W-135) polysaccharide diphtheria toxoid conjugate vaccine (Menactra, Sanofi Pasteur) in children aged as young as 9 months for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.
Poison Prevention Week stresses dangers of Rx, OTC poisonings
March 24th 2011The American College of Emergency Physicians and the American Association of Poison Control Centers are raising awareness about the dangers of drug poisoning as part of Poison Prevention Week, which is taking place March 20 to 26.
Coadministration of flu, pneumococcal vaccine increases risk of febrile seizure
March 15th 2011Children 6 to 23 months of age who receive trivalent inactivated flu vaccine concurrently with the 13-valent pneumococcal conjugate vaccine are at increased risk of febrile seizures, according to researchers at the CDC and Harvard Medical School.
FDA lopinavir/ritonavir label change warns of serious health risks to premature babies
March 14th 2011FDA notified healthcare professionals of serious health risks that have been reported in premature babies receiving lopinavir/ritonavir (Kaletra, Abbott) oral solution. Lopinavir/ritonavir oral solution contains the ingredients alcohol and propylene glycol.
Corticosteroids' safety affirmed in treatment of childhood asthma
March 8th 2011Children being treated with a short course of oral corticosteroids for an acute asthma attack may experience a brief and transient depression of their immune response, according to a recent study conducted by Université de Montréal.
FDA approves head lice treatment for children and adults
January 19th 2011FDA approved spinosad (Natroba, ParaPRO LLC) Topical Suspension 0.9% for the treatment of head lice infestation in patients aged 4 years and older. Natroba is a topical drug product and should be applied only to the child's scalp or hair.